Alvimopan
- Level
- Commodity
- Parent
- 51171600
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51171634This classification denotes an opiate antagonist with the molecular formula C25H32N2O4.2H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 677C126AET, chemically known as glycine, n-((2s)-2-(((3r,4r)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl)methyl)-1-oxo-3-phenylpropyl)-, dihydrate but generally known as alvimopan, which bears US NIH Compound Identifier 5488547. Alvimopan most often comes in simple, anhydrous, and hyrdate forms. European Medicines Agency schedules Alvimopan in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB20585. World Health Organization schedules alvimopan in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule alvimopan under HS 29333999 and SITC 51574. As of Q4 2014, ALVIMOPAN remains the US FDA Preferred Term for this commodity. Alvimopan bears US NLM identifiers UMLS ID C1508750 and NCI Concept Code C49096. SMILES: OC1CC(C2(C(CN(CC2)CC(CC2CCCCC2)C(=O)NCC(=O)O)C)C)CCC1.O.O.
Same parent
Under 51171600 · 42Activities that produce or sell this
KBLI · 9Inherited from family 51170000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.